Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Treatment

Mostrar otras versiones (1)

The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evidence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mild...

Descripción completa

Detalles Bibliográficos
Autores principales: Youn, Jong-Chan, Kim, Darae, Cho, Jae Yeong, Cho, Dong-Hyuk, Park, Sang Min, Jung, Mi-Hyang, Hyun, Junho, Cho, Hyun-Jai, Park, Seong-Mi, Choi, Jin-Oh, Chung, Wook-Jin, Yoo, Byung-Su, Kang, Seok-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Cardiology 2023
Materias:
Clinical Practice Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172201/
https://www.ncbi.nlm.nih.gov/pubmed/37161681
http://dx.doi.org/10.4070/kcj.2023.0047
Descripción
Sumario:The Korean Society of Heart Failure (KSHF) guidelines aim to provide physicians with evidence-based recommendations for the management of patients with heart failure (HF). After the first introduction of the KSHF guidelines in 2016, newer therapies for HF with reduced ejection fraction, HF with mildly reduced ejection fraction, and HF with preserved ejection fraction have since emerged. The current version has been updated based on international guidelines and research data on Korean patients with HF. Herein, we present Part II of these guidelines, which comprises treatment strategies to improve the outcomes of patients with HF.

Ejemplares similares